Radar › Screener › VIVS

VIVS

VivoSim Labs, Inc.
VIVS stock: dilution — what the SEC filings say, updated every weekday morning.
Nasdaq · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 1497253) · 3 signals · 0 setups · updated Sep 22, 2026

What the filings say Pressure ▼

Less than six months of cash at the latest burn — the company must raise, cut, or both, soon.

Radar 54 (elevated attention) · dilution pressure high · listing risk low · governance risk low · runway 1.9 mo · strongest signal: Share count +25% (Jun 30, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

Get tomorrow's read on VIVS — free
One email every weekday morning: what changed across VIVS and ~1,400 other microcaps, every claim linked to the filing.
54Radar · attention score (0–100)
71Dilution pressure · financing + balance sheet
0Listing risk · exchange standards
0Governance risk · reporting, auditor, going concern

Analyst note full note in Pro

Aug 16, 2026 · VIVS · red-team verdict publish with caveats

VivoSim Labs facing Nasdaq equity deficiency, 1.9-month runway despite $9M raised July 2026

VivoSim Labs received a Nasdaq notice on July 24, 2026, stating it failed to maintain the $2.5 million minimum stockholders' equity requirement under Listing Rule 5550(b)(1), based on its March 31, 2026 fiscal year-end equity deficit of $(1.1) million. The company must submit a compliance plan by September 3, 2026, and may receive up to 180 days (until January 16, 2027) to cure. Despite closing a $4 million PIPE on July 17, 2026, and receiving a $5 million milestone payment from Eli Lilly in July 2026 (both post-balance-sheet events), the June 30, 2026 balance sheet still showed negative equity of $(2.3) million and cash of $1.67 million against a $10.8 million annual burn rate.

Full note (what we noticed, why it may matter, evidence, what could prove us wrong, red-team caveats) is in the Pro digest →

Pro on VIVS
Alerts
One email the morning VIVS files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for VIVS back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 892 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$1.7Mcash + short-term investments as of Jun 30, 2026
1.9 moestimated runway (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts])
$-2.3Mstockholders' equity as of Jun 30, 2026
$7.5Mpublic float (10-K cover)
14.9Mshares outstanding as of Aug 10, 2026 · was 3.5M Jul 10, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 84 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Jun 30, 2026▼ Share count +25% Shares outstanding 3,494,071 (2026-07-10) -> 14,850,612 (2026-08-10), +325% filing 46
Jun 30, 2026▼ Runway < 6 months ~1.9 months runway: liquidity $1,670,000 as of 2026-06-30, burn $10,827,000/yr (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts]) filing 42
Jun 30, 2026▼ Negative equity Stockholders' equity $-2,346,000 as of 2026-06-30 filing 31
Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans